Lynch syndrome/Hereditary Non-polyposis Colorectal Cancer (HNPCC)

Minerva Gastroenterologica e Dietologica

Volumn 56, Issue 1, 2010, Pages 45-53

  Stoffel, E M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Colorectal tumor; Genetics; Lynch syndrome

Indexed keywords

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CLINICAL FEATURE; COLONOSCOPY; COLORECTAL CANCER; ENDOMETRIUM CANCER; FAMILIAL CANCER; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC IDENTIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MLH1 GENE; MLH2 GENE; MLH6 GENE; MORBIDITY; MUTATION; PHENOTYPE; PMS2 GENE; PROTEIN EXPRESSION; REVIEW; TUMOR GENE; UTERUS CANCER;

ALGORITHMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; HUMANS;

EID: 77952404668     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003;348:919-932
2. de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G et al. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum 2002;45:1588-1594
3. Mecklin JP, Aarnio M, Laara E, Kairaluoma MV, Pylvänäinen K, Peltomäki P et al. Development of colorectal tumors in colonoscopic surveillance in lynch syndrome. Gastroenterology 2007;133:1093-1098
4. Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 2009;137:1621-1627
5. Aarnio M, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999;81:214-218
6. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995;64:430-433
7. Warthin A. Heredity with reference of carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan 1895-1913. Arch Intern Med 1913;12:546-555
8. Lynch H, Shaw MW, Magnuson CW, Larsen AL, Krush AJ. Hereditary factors in cancer: study of two large Midwestern kindreds. Arch Intern Med 1966;117:206-212
9. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-425
10. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-816
11. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-819
12. Lindblom A, Tannergard P, Werelius B, Nordenskjold M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet 1993;5:279-282
13. Peltomaki P, Aaltonen LA, Sistonen P, Pylkkänen L, Mecklin JP, Järvinen H et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993;260:810-812
14. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994;368:258-261
15. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-1038 (Pubitemid 24014559)
16. Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, Igari T et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997;17:271-272
17. Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80. (Pubitemid 24277467)
18. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 2008;26:5783-5788
19. Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR. Review of the Lynch Syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 2009;76:1-18..
20. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997;89:1758-1762
21. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261-268 (Pubitemid 38256271)
22. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-110 (Pubitemid 27033972)
23. Hampel H, Frankel W, Panescu J, Lockman J, Sotamaa K, Fix D etal. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 2006;66:7810-7817
24. Lu KH, Schorge JO, Rodabaugh KJ, Daniels MS, Sun CC, Soliman PT et al. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer. J Clin Oncol 2007;25:5158-5164
25. Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM et al. Risk of pancreatic cancer in families with Lynch syndrome. JAMA 2009;302:1790-1795
26. Eisen DB, Michael DJ. Sebaceous lesions and their associated syndromes: part II. J Am Acad Dermatol 2009;61:563-78; quiz 579-580.
27. Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 2004;127:17-25.
28. Goecke T, Schulmann K, Engel C, Holinski-Feder E, Pagenstecher C, Schackert HK et al. Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol 2006;24:4285-4292
29. Kastrinos F, Stoffel EM, Balmana J, Steyerberg EW, Mercado R, Syngal S. Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States. Cancer Epidemiol Biomarkers Prev 2008;17:2044-2051
30. Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 2008;135:419-428
31. Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005;293:1979-1985
32. Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006;296:1507-1517 (Pubitemid 44465515)
33. Winawer SJ, Fietcher R, Rex D, Bonel J, Burt R, Ferrucci J et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale: Update based on new evidence. Gastroenterology 2003;124:544-560
34. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomäki P et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;118:829-834 (Pubitemid 30243745)
35. Hurlstone DP, Karajeh M, Cross SS, McAlindon ME, Brown S, Hunter MD et al. The role of high-magnification-chromoscopic colonoscopy in hereditary non-polyposis colorectal cancer screening: a prospective "back-to- back" endoscopic study. Am J Gastroenterol 2005;100:2167-2173
36. Lecomte T, Cellier C, Meatchi T, Barbier JP, Cugnenc PH, Jian R et al. Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome. Clin Gastroenterol Hepatol 2005;3:897-902. (Pubitemid 41219293)
37. Stoffel EM, Turgeon DK, Stockwell DH, Zhao L, Normolle DP, Tuck MK et al. Missed adenomas in during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res 2008;1:470-475
38. Jarvinen HJ, Renkonen-Sinisalo L, Aktan-Collan K, Peltomaki P, Aaltonen LA, Mecklin JP. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 2009;27:4793-4797
39. Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006;354:261-269
40. Kwon JS, Sun CC, Peterson SK, White KG, Daniels MS, Boyd-Rogers SG et al. Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome. Cancer 2008;113:326-335
41. Koornstra JJ, Mourits MJ, Sijmons RH, Leliveld AM, Hollema H, Kleibeuker JH. Management of extracolonic tumours in patients with Lynch syndrome. Lancet Oncol 2009;10:400-408
42. Balmana J, Stockwell DH, Steyerberg EW, Stoffel EM, Deffenbaugh AM, Reid JE et al. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 2006;296:1469-1478 (Pubitemid 44465511)
43. Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteous ME et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 2006;354:2751-2763
44. Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 2006;296:1479-1487
45. American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. Gastroenterology 2001;121:195-197
46. Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary non-polyposis colorectal cancer. Ann Intern Med 2001;135:577-588
47. Mvundura M, Grosse SD, Hampel H, Palomaki GE. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. 2010 Jan 15. [Epub ahead of print].
48. Hadley DW, Jenkins JF, Dimond E, de Carvalho M, Kirsch I, Palmer CG. Colon cancer screening practices after genetic counseling and testing for hereditary non-polyposis colorectal cancer. J Clin Oncol 2004;22:39-44. (Pubitemid 41095112)
49. Wagner A, van Kessel I, Kriege MG, Tops CM, Wijnen JT, Vasen HF et al. Long Term Follow-up of HNPCC Gene Mutation Carriers: Compliance with Screening and Satisfaction with Counseling and Screening Procedures. Fam Cancer 2005;4:295-300. (Pubitemid 41795804)
50. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003;21:2397-2406